Advertisement
Advertisement
U.S. markets closed
S&P Futures
4,016.25 +15.00 (+0.37%) Dow Futures
32,548.00 +114.00 (+0.35%) Nasdaq Futures
12,923.00 +32.75 (+0.25%) Russell 2000 Futures
1,758.30 +10.60 (+0.61%) Crude Oil
69.61 +0.35 (+0.51%) Gold
1,976.70 -7.10 (-0.36%)
At close: 04:03PM EDT
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 104.23 |
| Open | 104.09 |
| Bid | 104.30 x 1200 |
| Ask | 104.99 x 1100 |
| Day's Range | 102.44 - 105.01 |
| 52 Week Range | 80.73 - 115.49 |
| Volume | |
| Avg. Volume | 8,756,891 |
| Market Cap | 266.044B |
| Beta (5Y Monthly) | 0.35 |
| PE Ratio (TTM) | 18.26 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.92 (2.80%) |
| Ex-Dividend Date | Mar 14, 2023 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-8% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for MRK
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Merck & Company, Inc.Market Digest: LVS, MRK, NSC, GNRC, DOCUStocks held up on March 13 after some ugly early action that saw the S&P 500 (SPX) down about 1.3%. The index rallied almost 100 points by late morning before selling off over the balance of the day. It was a great session for day traders, but created more agita for the rest of us. The morning low coincided with chart support in the 3,780-3,810 region from the late-December low. On March 14, gains were solid and broad-based.RatingFair ValueEconomic Moat12 days agoArgus Research
- Investopedia
Who Are Pfizer's (PFE) Main Competitors?
Pfizer's biggest competitors in the global pharmaceutical industry are Johnson & Johnson, Roche, Eli Lilly, AbbVie, Novo Nordisk, and Merck.
- Zacks
The Zacks Analyst Blog Highlights Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton
Merck, Intel, MercadoLibre, The Travelers Companies and Halliburton are part of the Zacks top Analyst Blog.
- Zacks
Merck (MRK) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Merck (MRK) closed at $105.54, marking a -0.29% move from the previous day.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
